How have MTACU shares performed in 2023?

MedTech Acquisition's stock was trading at $10.11 at the beginning of the year. Since then, MTACU shares have increased by 12.3% and is now trading at $11.35. View the best growth stocks for 2023 here .

How do I buy shares of MedTech Acquisition?

Shares of MTACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

MedTech Acquisition Stock Price, News & Analysis (OTCMKTS:MTACU)

$11.35

+1.85 (+19.47%)

(As of 08/10/2023)

Compare

Today's Range: $10.00
▼
$11.35
50-Day Range: $11.35
▼
$11.35
52-Week Range: $9.23
▼
$11.43

Volume: 1,900 shs
Average Volume: 585 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings

About MedTech Acquisition Stock (OTCMKTS:MTACU)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

MTACU Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MTACU Stock News Headlines

November 28, 2023 | forbes.com

Investment News: Regulator To Crack Down On Product ‘Greenwashing’

November 22, 2023 | americanbankingnews.com

MedTech Acquisition (OTCMKTS:MTACU) Trading 19.5% Higher

November 29, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

October 28, 2023 | finance.yahoo.com

Gentex Corporation (NASDAQ:GNTX) Q3 2023 Earnings Call Transcript

October 28, 2023 | msn.com

Apple, Fed Meeting, Caterpillar, Jobs Report; Investing Action Plan

October 12, 2023 | markets.businessinsider.com

Xtant Medical Highlights Growing Product Portfolio at NASS 2023

August 15, 2023 | finance.yahoo.com

Magnetar Financial LLC Acquires Shares in MedTech Acquisition Corp

August 10, 2023 | finance.yahoo.com

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation

November 29, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

July 28, 2023 | finance.yahoo.com

Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp

July 26, 2023 | msn.com

J&J's Medtech Business Is Soaring. Time to Buy the Stock?

June 12, 2023 | finance.yahoo.com

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

February 14, 2023 | msn.com

Cork medtech company acquired by German firm

December 7, 2022 | finance.yahoo.com

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

November 15, 2022 | msn.com

Medtech giant Cordis acquires MedAlliance in a US $1.1Billion deal

November 13, 2022 | finance.yahoo.com

MedTech Acquisition Corporation (MTACU)

September 24, 2022 | morningstar.com

LAVA Medtech Acquisition Corp Ordinary Shares - Class A

August 23, 2022 | bizjournals.com

Standard Bariatrics, one of city's top-funded startups, sold in $300M deal

August 8, 2022 | apnews.com

Bain & Company and Trinity Life Sciences announce strategic partnership

July 13, 2022 | msn.com

Infosys to acquire tech and consulting firm BASE life science

July 9, 2022 | startribune.com

How Medtronic's billion-dollar HeartWare device went bust

June 16, 2022 | bizjournals.com

Boston Scientific to buy Korean medtech manufacturer for $230M

March 14, 2022 | finance.yahoo.com

Robotic surgery company Memic pulls out of SPAC merger

March 10, 2022 | finance.yahoo.com

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

October 7, 2021 | finance.yahoo.com

Is MedTech Acquisition Corporation (NASDAQ:MTAC) Popular Amongst Institutions?

August 28, 2021 | morningstar.com

MedTech Acquisition Corp MTACU

August 19, 2021 | finance.yahoo.com

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

See More Headlines

Receive MTACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Shell Companies
Sub-Industry: N/A
Sector: Financial Services
Current Symbol: OTCMKTS:MTACU
CUSIP: N/A
CIK: 1826667
Web: N/A
Phone: 908-391-1288
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Christopher C. Dewey (Age 79)
CEO & Director
Mr. David J. Matlin J.D. (Age 61)
CFO & Director
Mr. Robert H. Weiss J.D. (Age 64)
Chief Admin. Officer & Sec.

Key Competitors

View All Competitors

MTACU Stock Analysis - Frequently Asked Questions

How have MTACU shares performed in 2023?: MedTech Acquisition's stock was trading at $10.11 at the beginning of the year. Since then, MTACU shares have increased by 12.3% and is now trading at $11.35.
View the best growth stocks for 2023 here.
How do I buy shares of MedTech Acquisition?: Shares of MTACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:MTACU) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial